Annual report pursuant to Section 13 and 15(d)

Timeline Labs Acquisition and Loss on Impairment (Tables)

v3.3.1.900
Timeline Labs Acquisition and Loss on Impairment (Tables)
12 Months Ended
Jan. 31, 2016
Business Combinations [Abstract]  
Summary of Allocation of Purchase Price

The allocation of the purchase price was as follows (amounts in thousands):

 

Fair value of consideration:

  

Cash, net of cash acquired

   $ 14,186   

Closing stock consideration

     3,019   

Deferred stock consideration

     4,959   

Contingent consideration

     475   
  

 

 

 

Total purchase price

   $ 22,639   
  

 

 

 

Fair value of assets acquired and liabilities assumed:

  

Current assets

     95   

Other long-term assets

     108   

Finite-life intangible assets

     6,720   

Goodwill

     15,787   

Current liabilities

     (71
  

 

 

 

Allocated purchase price

   $ 22,639